<< Back To Authors

Overview

Liz Highleyman

Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.

Articles

Loneliness Linked to Frailty in Older People With HIV

Findings underscore the importance of recognizing and addressing social isolation among people aging with HIV.

First Clade I Mpox Case Reported in United States

The likelihood of a U.S. outbreak is deemed to be low, but health officials are urging people at higher risk to get vaccinated.

Two-Drug Regimen Works Well for People With Advanced HIV

Additional data show Dovato (dolutegravir/lamivudine) is also a feasible option when drug-resistance testing is unavailable.

HIV and Your Kidneys

Maintaining viral suppression is one of the best ways to preserve kidney function.

illustation magnifying glass looking at intestines colon

New Anal Cancer Screening Guidelines

Recommendations for people living with HIV now include anal cancer prevention.

Daily DoxyPrEP Prevents STIs

It’s another option for people who have sex often.

Olanzapine and Cannabis Can Help Manage Nausea During Chemotherapy

Recent studies showed that a drug approved for schizophrenia and a cannabis extract relieved nausea and improved quality of life.

Weekly Oral HIV Treatment Continues to Look Promising

A once-weekly combination of lenacapavir and islatravir pills maintained viral suppression for 48 weeks.

Hot topics

Nurse applying vaccine on patient's arm using face mask

COVID-19 101

Uterine Fibroids 101

Can Black Women Be Convinced That PrEP Isn’t Just for Gay Men?

A Less Painful Way for Diabetes Patients to Monitor Their Blood Sugar

Tress-Essential Elements

mother daughter talking to doctor smiling

Cancer and Quality of Life: A Special Report

Physical Activity May Reduce Risk of Falls for Older Cancer Patients

People who talked with their doctors about physical activity were 21% less likely to experience falls.

Dapivirine vaginal ring on blue gloved hand

3-Month Vaginal Ring Could Offer Longer-Lasting Protection Against HIV

Some women prefer the ring even though it’s less effective than daily PrEP pills or long-acting injections.

Twice-Yearly Lenacapavir PrEP Highly Effective in Second Study

Results for gay men and gender-diverse people confirm stellar HIV prevention findings for women reported this summer.

Needs of Older People With HIV Are Going Unmet

The U.S. is not on track to meet 2025 goals for self-rated health, mental health services, employment, adequate food or stable housing.

vial and needle vaccine injection medication

ViiV Will Triple Annual Supply of Long-Acting PrEP for Low and Middle-Income Countries

At least 2 million doses of Apretude will be made available to meet growing demand where unmet need is greatest.

Gilead Signs Voluntary Licensing Agreements for Lenacapavir PrEP

Advocates welcome the agreement, but some say it should not be limited only to lower-income countries.

Pain Management Program Shows Promise for People With HIV

Study participants experienced significant improvements in pain severity, functional impairment and depression.

High-Dose Vitamin D Doesn’t Help Most Patients With Metastatic Colorectal Cancer

However, study results suggest higher doses may benefit patients with tumors on the left side of the colon or rectum.